EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Comparative Effectiveness of Monotherapy Versus Combination Therapy in Vitiligo: A Mixed‐Effects Model Analysis of Longitudinal VASI Scores

Amr Molla, Salman Althobaiti

Dermatologic Therapy · 2026-01 · 2026 (1)

DOI: 10.1155/dth/7443487 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Dermatologic Therapy, online erschienen am 31.01.2026. Verfasst von Amr Molla und 1 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Direct evidence comparing single‐agent and combination regimens for vitiligo is limited and often overlooks longitudinal outcomes. This study evaluated how combination therapy versus monotherapy influenced repigmentation, measured by the Vitiligo Area Scoring Index (VASI), in a real‐world clinical setting.

Objective

To compare the effectiveness of monotherapy versus combination therapy in vitiligo treatment using longitudinal VASI scores, adjusting for demographic and clinical confounders.

Methods

We retrospectively reviewed records from two tertiary centers in Saudi Arabia (Jan 2018–Dec 2023). A total of 500 patients (52% female; aged 1–75 years) contributed approximately 5,000 visit‐level VASI scores over 12 months. Treatment was classified as monotherapy ( n = 179) or combination therapy ( n = 321). Linear mixed‐effects models with random intercepts and patient‐specific slopes were applied. Fixed effects included therapy modality, visit order, age, sex, nationality, and vitiligo phenotype. Model selection was based on Akaike/Bayesian information criteria and likelihood ratio tests.

Results

The best‐fit model included a therapy‐by‐visit interaction. Combination therapy was associated with a 2.1‐point lower baseline VASI than monotherapy ( p < 0.001), with greater reductions over time (−0.31 per visit; p < 0.001). Genital, focal, and acrofacial types responded best; universal vitiligo worsened. Age predicted poorer response; sex and nationality were nonsignificant. ICC = 0.95; marginal and conditional R 2 were 0.42 and 0.97, respectively.

Conclusion

Combination regimens offer faster and more sustained VASI improvements than monotherapy, particularly in extensive or aggressive vitiligo. These findings support personalized treatment strategies incorporating NB‐UVB or JAK inhibitors and highlight the importance of phenotype‐based care. Further head‐to‐head trials and meta‐analyses are needed to refine regimen selection and address interpatient variability.

Zitieren

APA

Molla, A., & Althobaiti, S. (2026). Comparative Effectiveness of Monotherapy Versus Combination Therapy in Vitiligo: A Mixed‐Effects Model Analysis of Longitudinal VASI Scores. Dermatologic Therapy, 2026(1). https://doi.org/10.1155/dth/7443487

Vancouver

Molla A, Althobaiti S. Comparative Effectiveness of Monotherapy Versus Combination Therapy in Vitiligo: A Mixed‐Effects Model Analysis of Longitudinal VASI Scores. Dermatologic Therapy. 2026;2026(1). doi:10.1155/dth/7443487

BibTeX
@article{Molla2026,
  author = {Molla, Amr and Althobaiti, Salman},
  title = {Comparative Effectiveness of Monotherapy Versus Combination Therapy in Vitiligo: A Mixed‐Effects Model Analysis of Longitudinal VASI Scores},
  journal = {Dermatologic Therapy},
  year = {2026},
  volume = {2026},
  number = {1},
  doi = {10.1155/dth/7443487}
}
Kostenlos starten →